JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 116 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $247,308 | +66.7% | 133,680 | 0.0% | 0.00% | – |
| Q4 2022 | $148,384 | -56.2% | 133,680 | -7.6% | 0.00% | – |
| Q3 2022 | $339,000 | -11.5% | 144,700 | +14.5% | 0.00% | – |
| Q2 2022 | $383,000 | -55.7% | 126,410 | -0.7% | 0.00% | – |
| Q1 2022 | $865,000 | -18.5% | 127,252 | +0.2% | 0.00% | – |
| Q4 2021 | $1,062,000 | +11.6% | 127,005 | -0.8% | 0.00% | – |
| Q3 2021 | $952,000 | +37.0% | 128,079 | +25.2% | 0.00% | – |
| Q2 2021 | $695,000 | -4.9% | 102,268 | +43.7% | 0.00% | – |
| Q1 2021 | $731,000 | +45.0% | 71,171 | -1.2% | 0.00% | – |
| Q4 2020 | $504,000 | -66.8% | 72,040 | -61.3% | 0.00% | – |
| Q3 2020 | $1,520,000 | +9.7% | 186,287 | -7.2% | 0.00% | – |
| Q2 2020 | $1,385,000 | +39.5% | 200,650 | -4.0% | 0.00% | – |
| Q1 2020 | $993,000 | -48.3% | 209,007 | -5.1% | 0.00% | – |
| Q4 2019 | $1,922,000 | +576.8% | 220,131 | +158.5% | 0.00% | – |
| Q3 2019 | $284,000 | -32.5% | 85,166 | +0.2% | 0.00% | – |
| Q2 2019 | $421,000 | +0.2% | 85,021 | +25.4% | 0.00% | – |
| Q1 2019 | $420,000 | +80.3% | 67,803 | -1.8% | 0.00% | – |
| Q4 2018 | $233,000 | -24.6% | 69,068 | +45.1% | 0.00% | – |
| Q3 2018 | $309,000 | -15.3% | 47,593 | +0.1% | 0.00% | – |
| Q2 2018 | $365,000 | -66.4% | 47,568 | -2.2% | 0.00% | – |
| Q1 2018 | $1,087,000 | +85.8% | 48,640 | +6.0% | 0.00% | – |
| Q4 2017 | $585,000 | -9.4% | 45,889 | +10.8% | 0.00% | – |
| Q3 2017 | $646,000 | +79.9% | 41,422 | +62.0% | 0.00% | – |
| Q2 2017 | $359,000 | -6.8% | 25,574 | +46.0% | 0.00% | – |
| Q1 2017 | $385,000 | – | 17,511 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |